Feds Indict Fugitive CEO, CFO For $426M Securities Scheme
Two top-level executives from a bankrupt Chinese medical technology company are on the run from authorities after stealing more than $426 million from investors in a fraudulent note offering scheme, prosecutors...To view the full article, register now.
Already a subscriber? Click here to view full article